BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹4.53 | ₹4.68 | ₹1.64 | ₹3.79 | ₹3.20 |
What is the latest Earnings Per Share (EPS) of BAL PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹4.53 |
| Mar2024 | ₹4.68 |
| Mar2023 | ₹1.64 |
| Mar2022 | ₹3.79 |
| Mar2021 | ₹3.20 |
How is Earnings Per Share (EPS) of BAL PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.53 | -3.21 | |
| Mar2024 | ₹4.68 | 185.37 | |
| Mar2023 | ₹1.64 | -56.73 | |
| Mar2022 | ₹3.79 | 18.44 | |
| Mar2021 | ₹3.20 | - | |
Compare Earnings Per Share (EPS) of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹138.1 Cr | 1.4% | -1.5% | -7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 1.4% |
-1.5% |
-7% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses